Concepedia

James P. Rizzi

JP

22

Publications

2.6K

Citations

20

H-Index

1979

Active since

Affiliations

Pfizer (United States)(Current)

Array BioPharma (United States)

University of Rochester

Cellerant Therapeutics (United States)

The University of Texas Southwestern Medical Center

James P. Rizzi is an author at Pfizer (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1979–2018

22

Publications

22

Targeting renal cell carcinoma with a HIF-2 antagonist

Wenfang Chen, Haley Hill, Alana Christie et al. · Nature · 2016 · 697 citations · Full text

, , +4

On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models

Hyejin Cho, Xinlin Du, James P. Rizzi et al. · Nature · 2016 · 441 citations · Full text

, , +7

A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma

Eli M. Wallace, James P. Rizzi, Guangzhou Han et al. · Cancer Research · 2016 · 310 citations

Topology of the pore-region of a K+ channel revealed by the NMR-derived structures of scorpion toxins

Jayashree Aiyar, Jane M. Withka, James P. Rizzi et al. · Neuron · 1995 · 254 citations · Full text

, , +8

The Signature Sequence of Voltage-gated Potassium Channels Projects into the External Vestibule

Jayashree Aiyar, James P. Rizzi, George A. Gutman et al. · Journal of Biological Chemistry · 1996 · 128 citations · Full text

, , +21

Rows per page

1–5 of 22